Unraveling the complex interplay: immunopathology and immune evasion strategies of alphaviruses with emphasis on neurological implications

被引:2
|
作者
Souza, Raquel de Oliveira [1 ]
Duarte Junior, Jose Wandilson Barboza [1 ]
Della Casa, Victoria Simoes [1 ]
Rosa, Daniela Santoro [2 ]
Renia, Laurent [3 ,4 ,5 ]
Claser, Carla [1 ,2 ]
机构
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil
[2] Fed Univ Sao Paulo UNIFESP, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil
[3] ASTAR, ASTAR Infect Dis Labs, ASTAR ID Labs, Singapore, Singapore
[4] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[5] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2024年 / 14卷
基金
巴西圣保罗研究基金会;
关键词
alphavirus; chikungunya; mayaro; mouse; coinfection; nervous system; immunopathology; immune evasion; VENEZUELAN EQUINE ENCEPHALITIS; CHIKUNGUNYA VIRUS-INFECTION; CENTRAL-NERVOUS-SYSTEM; SEMLIKI FOREST VIRUS; BLOOD-BRAIN-BARRIER; MOUSE MODEL; WILD-TYPE; DENDRITIC CELLS; ARTHRITOGENIC ALPHAVIRUSES; CIRCUMVENTRICULAR ORGANS;
D O I
10.3389/fcimb.2024.1421571
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Arthritogenic alphaviruses pose a significant public health concern due to their ability to cause joint inflammation, with emerging evidence of potential neurological consequences. In this review, we examine the immunopathology and immune evasion strategies employed by these viruses, highlighting their complex mechanisms of pathogenesis and neurological implications. We delve into how these viruses manipulate host immune responses, modulate inflammatory pathways, and potentially establish persistent infections. Further, we explore their ability to breach the blood-brain barrier, triggering neurological complications, and how co-infections exacerbate neurological outcomes. This review synthesizes current research to provide a comprehensive overview of the immunopathological mechanisms driving arthritogenic alphavirus infections and their impact on neurological health. By highlighting knowledge gaps, it underscores the need for research to unravel the complexities of virus-host interactions. This deeper understanding is crucial for developing targeted therapies to address both joint and neurological manifestations of these infections.
引用
收藏
页数:18
相关论文
共 7 条
  • [1] Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
    Yan-Ruide Li
    Tyler Halladay
    Lili Yang
    Journal of Biomedical Science, 31
  • [2] Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
    Li, Yan-Ruide
    Halladay, Tyler
    Yang, Lili
    JOURNAL OF BIOMEDICAL SCIENCE, 2024, 31 (01)
  • [3] Virulence and Immune Evasion Strategies of FMDV: Implications for Vaccine Design
    Medina, Gisselle N.
    Segundo, Fayna Diaz San
    VACCINES, 2024, 12 (09)
  • [4] Epstein-Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases
    Zhao, Yuehong
    Zhang, Qi
    Zhang, Botian
    Dai, Yihao
    Gao, Yifei
    Li, Chenzhong
    Yu, Yijing
    Li, Conglei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [5] Infections after a traumatic brain injury: The complex interplay between the immune and neurological systems
    Sharma, Rishabh
    Shultz, Sandy R.
    Robinson, Marcus J.
    Belli, Antonio
    Hibbs, Margaret L.
    O'Brien, Terence J.
    Semple, Bridgette D.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 79 : 63 - 74
  • [6] Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment
    Huang, Qibo
    Hu, Bai
    Zhang, Ping
    Yuan, Ye
    Yue, Shiwei
    Chen, Xiaoping
    Liang, Junnan
    Tang, Zhouping
    Zhang, Bixiang
    MOLECULAR CANCER, 2025, 24 (01)
  • [7] Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains
    Chang, YJ
    Jiang, M
    Lubinski, JM
    King, RD
    Friedman, HM
    VACCINE, 2005, 23 (38) : 4658 - 4665